Syschem (India) Ltd.
| BSE: 531173 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE121D01036 |
| BSE 00:00 | 26 Oct | 10.03 |
-0.47 (-4.48%) |
OPEN
9.99 |
HIGH
10.50 |
LOW
9.99 |
| NSE 05:30 | 01 Jan | Syschem (India) Ltd |
| OPEN | 9.99 |
| PREVIOUS CLOSE | 10.50 |
| VOLUME | 3246 |
| 52-Week high | 13.00 |
| 52-Week low | 5.58 |
| P/E | |
| Mkt Cap.(Rs cr) | 23 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Syschem (India) Ltd. (SYSCHEMINDIA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 703.80 | 18.45 | 2.69 | 3112.91 |
| Cipla | 907.30 | 5.40 | 0.60 | 2468.28 |
| Dr Reddy's Labs | 4667.70 | -7.75 | -0.17 | 2186.40 |
| Sun Pharma.Inds. | 813.55 | 0.55 | 0.07 | 2139.70 |
| Divi's Lab. | 5018.95 | 22.15 | 0.44 | 1954.72 |
| Alkem Lab | 3698.60 | -7.60 | -0.21 | 1685.08 |
| Glenmark Pharma. | 507.90 | 21.80 | 4.48 | 1649.45 |
| Cadila Health. | 509.00 | 10.75 | 2.16 | 1476.20 |
| Lupin | 929.80 | 2.20 | 0.24 | 1258.62 |
| Alembic Pharma | 756.30 | -5.55 | -0.73 | 1175.39 |
| Ipca Labs. | 2188.05 | -37.25 | -1.67 | 1140.77 |
| Torrent Pharma. | 2942.30 | -142.25 | -4.61 | 1137.85 |
| Gland Pharma | 3561.85 | -161.60 | -4.34 | 997.01 |
| Laurus Labs | 564.65 | 10.75 | 1.94 | 956.11 |
| Abbott India | 20188.90 | 115.10 | 0.57 | 690.69 |
| Ajanta Pharma | 2117.35 | -50.50 | -2.33 | 675.64 |
| Wockhardt | 434.85 | 3.25 | 0.75 | 593.29 |
| Granules India | 317.75 | 2.85 | 0.91 | 552.78 |
| Pfizer | 4988.25 | 16.95 | 0.34 | 497.61 |
| Sanofi India | 8091.45 | -184.40 | -2.23 | 477.60 |
Quick Links for Syschem (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
